These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5472233)

  • 21. Diurnal blood sugar levels and clinical experience during glibenclamide therapy.
    O'Sullivan DJ
    Postgrad Med J; 1970 Dec; ():Suppl:46-9. PubMed ID: 5533296
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 23. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
    Forattini C
    Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
    [No Abstract]   [Full Text] [Related]  

  • 25. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of glipizide on a double-meal test in diabetic patients.
    Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
    Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of glybenclamide, a hypoglycaemic agent.
    Walker RL
    Med J Aust; 1970 Nov; 2(22):1015-6. PubMed ID: 4924417
    [No Abstract]   [Full Text] [Related]  

  • 30. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
    Vailati G; Montini M; Pagani G; Caputo G
    Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypoglycemia after treatment with Glibenclamid (Euglucon 5)].
    Stötter G
    Munch Med Wochenschr; 1970 Nov; 112(48):2192-4. PubMed ID: 5536880
    [No Abstract]   [Full Text] [Related]  

  • 35. A clinical trial of glymidine (Gondafon).
    Mallinson CN; Chlouverakis K; Hardwick C; Mistry SJ; Butterfield WH
    Guys Hosp Rep; 1968; 117(4):267-74. PubMed ID: 4889379
    [No Abstract]   [Full Text] [Related]  

  • 36. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
    Villaseñor A
    Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
    [No Abstract]   [Full Text] [Related]  

  • 37. Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
    Cohen H; Clyne JR
    Postgrad Med J; 1970 Dec; ():Suppl:50-2. PubMed ID: 5533297
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risks of severe hypoglycemia after glibenclamide (daonil or euglucan). A report of 10 cases of coma observed during a period of 6 months].
    Raymond JP; Chimènes H; Klotz HP
    Diabete; 1971; 19(1):31-2. PubMed ID: 4999031
    [No Abstract]   [Full Text] [Related]  

  • 39. Glibenclamide.
    Br Med J; 1971 Jun; 2(5762):644-5. PubMed ID: 5580727
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
    Domingo Gutiérrez AJ
    Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.